The negative effects of the COVID-19 pandemic and the lockdown have driven people to develop eating disorders: new communication technologies paved the way to online psychological support.
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
Chronic exposure to smoke causes a progressive deterioration of the lung cilia, one of the defence mechanisms of the respiratory system.Switching to products without combustion, however, can dramatically reduce the…
“The results of LSR are of particular interest for lawmakers, clinicians, as well as the public seeking reliable information on e-cigarettes." The seminar “Living systematic reviews: a new standard for…
These are the professors: Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Sandro La Vignera, Venerando Rapisarda.
Polosa: “Let's go ahead steady and with determination towards innovative and functional research. We believe in an open, multidisciplinary, and globalised science that delivers knowledge locally and globally. A science…
Tuesday 16 November at 14.00 CET a seminar on "Living systematic review: a new standard for medical research questions" will be held online on the ZOOM Platform direct by dr. Renèe O'Leary,…
The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
